China CGM Devices Market Size & Trends
The China continuous glucose monitoring devices market size was estimated at USD 231.4 million in 2024 and is projected to grow at a CAGR of 19.4% from 2025 to 2033 to reach a value of USD 1.14 billion in 2033. The China continuous glucose monitoring (CGM) devices industry is expanding due to the sharp rise in diabetes cases, driven by urbanization, sedentary habits, and dietary shifts. A 2023 study shows 233 million diabetic patients in China is up 163% since 2005, with prevalence rising from 7.53% to 13.7%.This growing burden, along with enhanced public health awareness, improved healthcare infrastructure, and government support for advanced monitoring tools, is fueling CGM adoption. Integration with smartphones and wearables adds to user convenience. Manufacturers are investing in cost-effective innovations, and the rising demand for real-time glucose tracking is further boosting market growth across healthcare settings.
Initially developed for managing type 1 and type 2 diabetes, CGMs have gained widespread popularity beyond traditional use, particularly among young individuals seeking better lifestyle and health monitoring. Videos tagged “sugar control” on Douyin, China’s version of TikTok, have garnered over 20.8 billion vie, indicating massive interest. The wearable nature and real-time tracking capabilities of CGM devices have made them appealing to younger, tech-savvy users. Users now rely on CGMs for weight management and dietary planning, illustrating the market's shift toward preventive health behaviors.
According to Sinocare’s Director of CGM Consumer Business for China, sales of CGM needles surged by 63% year-on-year in H2 2024, while Sinocare’s sales doubled, growing by 104% on major platforms like T-mall and JD.com. This reflects both growing public interest and market penetration, especially among youth newly diagnosed or at risk for diabetes. Expert voices add credibility to this trend.
China Continuous Glucose Monitoring Devices Market Report Segmentation
This report forecasts revenue growth at country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the China continuous glucose monitoring devices market report based on product, connectivity, indication and end use.Product Outlook (Revenue, USD Million, 2021 - 2033)
- Standalone CGM Devices
- Devices
- Consumables (Receivers, Sensors, and Transmitters)
- Integrated CGM-Insulin Pump Systems
Connectivity Outlook (Revenue, USD Million, 2021 - 2033)
- Bluetooth
- 4G/Cellular
- NFC (Near Field Communication)
Indication Outlook (Revenue, USD Million, 2021 - 2033)
- Type 1 Diabetes
- Type 2 Diabetes
End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Pharmacies
- E-commerce
- Others
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. China CGM Devices Market Variables, Trends, & Scope
Chapter 4. China CGM Devices Market: Product Estimates & Trend Analysis
Chapter 5. China CGM Devices Market: Connectivity Estimates & Trend Analysis
Chapter 6. China CGM Devices Market: Indication Estimates & Trend Analysis
Chapter 7. China CGM Devices Market: End Use Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Abbott Laboratories
- Dexcom, Inc.
- Sinocare Inc.
- Medtronic plc
- Ascensia Diabetes Care
- Trinity Biotech
- MicroTech Medical
- Meiqi Medical
- Yuwell
- i-SENS Inc
